Transversus Abdominis Plane Block levobupivacaine plus ketamine in abdominoplasty

Transversus Abdominis Plane Block ¿TAP¿: A Comparative Study between levobupivacaine versus levobupivacaine plus ketamine in abdominoplasty

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201703002081320

Enrollment

Registered

2017-03-07

Start date

2016-06-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery perio-perative analgesia Anaesthesia

Interventions

TAP block with levopupivacaine .5% 15 ml plus ketamine 0.5 mg/kg in total volume 20

TAP block with levopupivacaine .5% 15 ml plus 5 ml normal saline in total volume 20

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients of American Society of Anesthesiologist (I, II), aged from 25 to 50 year of both sex undergoing abdominoplasty will be enrolled in the study

Exclusion criteria

Exclusion criteria: Body mass index ¿¿BMI¿¿ > 35 kg/m2, allergies to local anesthetic, alcohol or drug abuse, coagulation disorders, mental or physical illness interfere with evaluation of VAS

Design outcomes

Primary

Measure	Time frame
Postoperative pain	—

Secondary

Measure	Time frame
Overall patient satisfaction	—

Countries

Egypt

Contacts

Public ContactSameh Abd Elkhalik

lecturer of anesthesia and ICU

dr_sameh_100@yahoo.com0201002977048

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026